<DOC>
	<DOCNO>NCT02951247</DOCNO>
	<brief_summary>A methodical evaluation new CE-labelled Phonak Hearing Systems intend conduct hard hear participant grant quality control prior product launch . The aim investigation series ensure zero-defect overall performance new hear system well maximum benefit participant device comparison previously outstanding Phonak Hearing Systems .</brief_summary>
	<brief_title>Quality Control CE-Certified Phonak Hearing Aids - 2016_05</brief_title>
	<detailed_description>Phonak Hearing Systems pas different development study stage . At early stage , feasibility study conduct investigate new algorithm , feature function isolate manner . If benefit proven , performance investigate regard interdependency available algorithm , feature function run parallel hear aid ( pivotal/pre-validation study ) , result , get optimize . Afterwards , prior product launch , Phonak Hearing Systems undergo final quality control term clinical trial way plan study ( `` phase final inspection '' ) . This control , single blind randomised active comparator clinical evaluation conduct mono centric Sonova AG Headquarters base Stäfa ( Switzerland ) .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<criteria>Adult hearing impaired person ( minimum age : 18 year ) without ( experience ) hearing aid Good write speak ( Swiss ) German language skills Healthy outer ear Ability fill questionnaire ( p/eCRF ) conscientiously Informed Consent document signature Contraindications MD study , e.g . know hypersensitivity allergy investigational product Limited mobility position attend weekly appointment Stäfa ( Switzerland ) Limited ability describe listen impressions/experiences use hear aid Inability produce reliable hear test result Massively limited dexterity Known psychological problem Central hear disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>